Alesi, Simon

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · European Journal of Endocrinology

Ovarian function and disordersClinical practice guidelines implementation

Cited by 525

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., M. Redman, L., A. Boyle, J., et al. (2023) · Fertility and Sterility

Ovarian function and disordersClinical practice guidelines implementation

Cited by 417

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · Human Reproduction

Ovarian function and disordersClinical practice guidelines implementation

Cited by 244

Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis

Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A., Witchel, S. F., Mousa, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 78

The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials

Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A., Witchel, S. F., Mousa, A., et al. (2023) · European Journal of Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 72

Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review

Forslund, M., Melin, J., Alesi, S., Piltonen, T., Romualdi, D., Tay, C. T., Witchel, S., Pena, A., Mousa, A., & Teede, H. (2023) · Clinical Endocrinology

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 32

Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis

Melin, J. M., Forslund, M., Alesi, S. J., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A. S., Witchel, S. F., Mousa, A., et al. (2024) · Clinical Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 16

Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence

Alesi, S., Ghelani, D., & Mousa, A. (2021) · Seminars in Reproductive Medicine

Ovarian function and disordersMetabolomics and Mass Spectrometry Studies

Cited by 16

Supplementary Material. Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and meta-analysis.

Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena Vargas, A., Witchel, S. F., Mousa, A., et al. (2023) · Monash University

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 0